Interplay between male testosterone levels and the risk for subsequent invasive respiratory assistance among COVID-19 patients at hospital admission

This publication has 10 references indexed in Scilit:

• Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532)
  Annals of Oncology, 2020
• Commentary: Testosterone, a key hormone in the context of COVID-19 pandemic
  Metabolism, 2020
• Low testosterone levels predict clinical adverse outcomes in SARS‐CoV‐2 pneumonia patients
  Andrology, 2020
• scRNA-seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for SARS-CoV-2 Infection in Spermatogonia, Leydig and Sertoli Cells
  Cells, 2020
• Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
  The Lancet, 2020
• Sex and Gender Differences in the Outcomes of Vaccination over the Life Course
  Annual Review of Cell and Developmental Biology, 2017
• Suppressive effects of androgens on the immune system
  Cellular Immunology, 2015
• Higher serum testosterone and dihydrotestosterone, but not oestradiol, are independently associated with favourable indices of lung function in community‐dwelling men
  Clinical Endocrinology, 2015
• Androgens are bronchoactive drugs that act by relaxing airway smooth muscle and preventing bronchospasm
  Journal of Endocrinology, 2014
• Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
  The Journal of Clinical Endocrinology & Metabolism, 2001